| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C070379 |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of PLA2G4A mRNA | increases expression | 19933214
|
| C447028 |
2,2',4,6-tetrachlorobiphenyl |
PLA2G4A protein promotes the reaction [2,2',4,6-tetrachlorobiphenyl results in increased secretion of Arachidonic Acid] | increases reaction|increases secretion | 16120751
|
| C009407 |
2,5,2',5'-tetrachlorobiphenyl |
2,5,2',5'-tetrachlorobiphenyl affects the localization of and results in increased phosphorylation of PLA2G4A protein | affects localization|increases phosphorylation | 16290172
|
| C109986 |
2-aminoethoxydiphenyl borate |
[Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | affects cotreatment|decreases reaction|increases expression | 18938131
|
| C021296 |
2-ethoxyethanol |
2-ethoxyethanol results in increased expression of PLA2G4A mRNA | increases expression | 19643169
|
| D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 16603213
|
| D020106 |
Acrylamide |
Acrylamide analog results in decreased activity of PLA2G4A protein | decreases activity | 18287786
|
| D000255 |
Adenosine Triphosphate |
Adenosine Triphosphate results in increased activity of PLA2G4A protein | increases activity | 10535451
|
| D000535 |
Aluminum |
Aluminum affects the activity of PLA2G4A protein | affects activity | 17279785
|
| C041524 |
aluminum sulfate |
aluminum sulfate results in increased expression of PLA2G4A mRNA | increases expression | 15961160
|
| D016718 |
Arachidonic Acid |
AHR affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [PLA2G4A protein results in increased secretion of Arachidonic Acid]] | affects reaction|increases reaction|increases secretion | 19162293
|
| D016718 |
Arachidonic Acid |
PLA2G4A protein promotes the reaction [2,2',4,6-tetrachlorobiphenyl results in increased secretion of Arachidonic Acid] | increases reaction|increases secretion | 16120751
|
| C081565 |
arachidonyltrifluoromethane |
arachidonyltrifluoromethane inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| C081565 |
arachidonyltrifluoromethane |
arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131 19162293
|
| C081565 |
arachidonyltrifluoromethane |
arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 19063610
|
| D001241 |
Aspirin |
Aspirin results in decreased expression of PLA2G4A mRNA | decreases expression | 10706128
|
| D001554 |
Benzene |
Benzene affects the expression of PLA2G4A mRNA | affects expression | 15878777
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of PLA2G4A mRNA | increases expression | 20064835
|
| D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in increased expression of PLA2G4A protein | increases expression | 16443645
|
| D020122 |
tert-Butylhydroperoxide |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D020122 |
tert-Butylhydroperoxide |
arachidonyltrifluoromethane inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D020122 |
tert-Butylhydroperoxide |
calphostin C inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D020122 |
tert-Butylhydroperoxide |
Go 6976 inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D020122 |
tert-Butylhydroperoxide |
Pertussis Toxin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased activity of PLA2G4A protein | increases activity | 16291515
|
| D020122 |
tert-Butylhydroperoxide |
Vitamin E inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PLA2G4A mRNA | increases expression | 15336504
|
| C058819 |
calphostin C |
calphostin C inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| C459604 |
candoxin |
candoxin results in decreased expression of PLA2G4A mRNA | decreases expression | 16309724
|
| D002220 |
Carbamazepine |
Carbamazepine results in decreased expression of PLA2G4A mRNA | decreases expression | 15312812
|
| D002220 |
Carbamazepine |
Carbamazepine results in decreased expression of PLA2G4A protein | decreases expression | 15312812
|
| D002220 |
Carbamazepine |
Carbamazepine results in increased expression of PLA2G4A mRNA | increases expression | 17594078
|
| D002220 |
Carbamazepine |
Carbamazepine results in increased expression of PLA2G4A protein | increases expression | 17594078
|
| D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [TCFAP2A protein binds to PLA2G4A gene] | affects binding|decreases reaction | 16806101
|
| D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [TCFAP2B protein binds to PLA2G4A gene] | affects binding|decreases reaction | 16806101
|
| D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [TCFAP2C protein binds to PLA2G4A gene] | affects binding|decreases reaction | 16806101
|
| D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PLA2G4A mRNA | affects expression | 17484886
|
| C105934 |
celecoxib |
[celecoxib co-treated with docetaxel] results in decreased expression of PLA2G4A protein | affects cotreatment|decreases expression | 16052515
|
| C105934 |
celecoxib |
celecoxib inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] | decreases expression|decreases reaction | 15816863
|
| D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Dexamethasone inhibits the reaction [Zymosan results in increased activity of PLA2G4A protein]] | decreases reaction|increases activity | 10874129
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PLA2G4A mRNA | decreases expression | 20106945
|
| D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 9609743
|
| D003907 |
Dexamethasone |
Cycloheximide inhibits the reaction [Dexamethasone inhibits the reaction [Zymosan results in increased activity of PLA2G4A protein]] | decreases reaction|increases activity | 10874129
|
| D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 10874129
|
| D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [Zymosan results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 10874129
|
| D003907 |
Dexamethasone |
Dexamethasone results in decreased activity of PLA2G4A protein | decreases activity | 10874129
|
| D003907 |
Dexamethasone |
Dexamethasone results in decreased expression of PLA2G4A mRNA | decreases expression | 10874129
|
| D003907 |
Dexamethasone |
Dexamethasone results in decreased expression of PLA2G4A protein | decreases expression | 10874129
|
| D002945 |
Cisplatin |
Cisplatin results in increased expression of PLA2G4A mRNA | increases expression | 15471895 15464296
|
| D004155 |
Diphenhydramine |
Diphenhydramine inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 9609743
|
| D004050 |
Ditiocarb |
Acetylcysteine inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 16603213
|
| D004050 |
Ditiocarb |
Ditiocarb results in increased expression of PLA2G4A mRNA | increases expression | 16603213
|
| D004050 |
Ditiocarb |
Ditiocarb results in increased expression of PLA2G4A protein | increases expression | 16603213
|
| D004050 |
Ditiocarb |
Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] | affects reaction|increases expression | 16603213
|
| D004050 |
Ditiocarb |
Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A protein] | affects reaction|increases expression | 16603213
|
| D004050 |
Ditiocarb |
U 0126 inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 16603213
|
| D004050 |
Ditiocarb |
U 0126 inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A protein] | decreases reaction|increases expression | 16603213
|
| C067311 |
docetaxel |
[celecoxib co-treated with docetaxel] results in decreased expression of PLA2G4A protein | affects cotreatment|decreases expression | 16052515
|
| C046770 |
EGTA acetoxymethyl ester |
EGTA acetoxymethyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 19162293
|
| D015777 |
Eicosanoids |
PLA2G4A protein promotes the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids] | increases metabolic processing|increases reaction | 17369491
|
| D015777 |
Eicosanoids |
PLA2G5 protein promotes the reaction [Zymosan promotes the reaction [PLA2G4A protein results in increased metabolism of Eicosanoids]] | increases metabolic processing|increases reaction | 16407308
|
| D004958 |
Estradiol |
Estradiol results in decreased expression of PLA2G4A mRNA | decreases expression | 14664709
|
| D018690 |
Excitatory Amino Acid Agonists |
Excitatory Amino Acid Agonists results in increased expression of and results in increased phosphorylation of and results in increased activity of PLA2G4A protein | increases activity|increases expression|increases phosphorylation | 17550430
|
| D018690 |
Excitatory Amino Acid Agonists |
Excitatory Amino Acid Agonists results in increased expression of PLA2G4A mRNA | increases expression | 17550430
|
| D005472 |
Fluorouracil |
PLA2G4A protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
| D005473 |
Fluoxetine |
Fluoxetine results in increased expression of and results in increased phosphorylation of and results in increased activity of PLA2G4A protein | increases activity|increases expression|increases phosphorylation | 16636684
|
| D005473 |
Fluoxetine |
Fluoxetine results in increased stability of and results in increased expression of PLA2G4A mRNA | increases expression|increases stability | 16636684
|
| C065382 |
fluticasone |
fluticasone affects the localization of PLA2G4A protein | affects localization | 15753895
|
| D009240 |
N-Formylmethionine Leucyl-Phenylalanine |
PLA2G4A protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased metabolism of Leukotriene B4] | increases metabolic processing|increases reaction | 11741884
|
| C081021 |
Go 6976 |
Go 6976 inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131
|
| D007975 |
Leukotriene B4 |
PLA2G4A protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased metabolism of Leukotriene B4] | increases metabolic processing|increases reaction | 11741884
|
| D007975 |
Leukotriene B4 |
PLA2G4A protein promotes the reaction [Zymosan analog results in increased metabolism of Leukotriene B4] | increases metabolic processing|increases reaction | 11741884
|
| D006632 |
Histamine |
Dexamethasone inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 9609743
|
| D006632 |
Histamine |
Diphenhydramine inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 9609743
|
| D006632 |
Histamine |
Histamine results in increased expression of PLA2G4A mRNA | increases expression | 9609743
|
| D006632 |
Histamine |
L 663536 inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 9609743
|
| C060893 |
L 663536 |
L 663536 inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 9609743
|
| D008070 |
Lipopolysaccharides |
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 10874129
|
| D008070 |
Lipopolysaccharides |
PLA2G4A protein affects the susceptibility to [Lipopolysaccharides co-treated with Zymosan] | affects cotreatment|affects response to substance | 10881173
|
| D008070 |
Lipopolysaccharides |
PLA2G4A protein promotes the reaction [[Zymosan co-treated with Lipopolysaccharides] results in increased metabolism of Prostaglandins] | affects cotreatment|increases metabolic processing|increases reaction | 16787386
|
| D008094 |
Lithium |
Lithium results in increased expression of PLA2G4A mRNA | increases expression | 17594078
|
| D008094 |
Lithium |
Lithium results in increased expression of PLA2G4A protein | increases expression | 17594078
|
| D016651 |
Lithium Carbonate |
Lithium Carbonate results in increased expression of PLA2G4A mRNA | increases expression | 17594078
|
| D016651 |
Lithium Carbonate |
Lithium Carbonate results in increased expression of PLA2G4A protein | increases expression | 17594078
|
| C104810 |
methyl arachidonylfluorophosphonate |
methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131
|
| C005219 |
methyl cellosolve |
methyl cellosolve results in increased expression of PLA2G4A mRNA | increases expression | 19643169
|
| C008493 |
methylselenic acid |
methylselenic acid results in increased expression of PLA2G4A mRNA | increases expression | 18548127
|
| C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131
|
| D009543 |
Nifedipine |
[Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | affects cotreatment|decreases reaction|increases expression | 18938131
|
| D009543 |
Nifedipine |
Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 19162293
|
| D009569 |
Nitric Oxide |
Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] | affects reaction|increases expression | 16603213
|
| D009569 |
Nitric Oxide |
Nitric Oxide affects the reaction [Ditiocarb results in increased expression of PLA2G4A protein] | affects reaction|increases expression | 16603213
|
| C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of PLA2G4A mRNA | increases expression | 17616710
|
| D010126 |
Ozone |
Ozone results in increased expression of PLA2G4A protein | increases expression | 12855403
|
| D010126 |
Ozone |
SOD1 protein inhibits the reaction [Ozone results in increased expression of PLA2G4A protein] | decreases reaction|increases expression | 12855403
|
| C508075 |
Pam(3)CSK(4) peptide |
PLA2G4A protein promotes the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids] | increases metabolic processing|increases reaction | 17369491
|
| D037342 |
Pertussis Toxin |
Pertussis Toxin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D011374 |
Progesterone |
Progesterone results in increased expression of PLA2G4A mRNA | increases expression | 18070364
|
| D011453 |
Prostaglandins |
PLA2G4A protein promotes the reaction [[Zymosan co-treated with Lipopolysaccharides] results in increased metabolism of Prostaglandins] | affects cotreatment|increases metabolic processing|increases reaction | 16787386
|
| C116926 |
rofecoxib |
rofecoxib inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] | decreases expression|decreases reaction | 15816863
|
| D012906 |
Smoke |
Smoke results in increased expression of PLA2G4A mRNA | increases expression | 17255567
|
| D013467 |
Sulindac |
Sulindac inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] | decreases expression|decreases reaction | 15816863
|
| D013467 |
Sulindac |
Sulindac results in decreased expression of PLA2G4A mRNA | decreases expression | 10706128
|
| D013629 |
Tamoxifen |
PLA2G4A mRNA results in decreased susceptibility to Tamoxifen | decreases response to substance | 21119660
|
| C011363 |
terephthalic acid |
terephthalic acid results in increased expression of PLA2G4A mRNA | increases expression | 16621493
|
| D013749 |
Tetrachlorodibenzodioxin |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131
|
| D013749 |
Tetrachlorodibenzodioxin |
AHR affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [PLA2G4A protein results in increased secretion of Arachidonic Acid]] | affects reaction|increases reaction|increases secretion | 19162293
|
| D013749 |
Tetrachlorodibenzodioxin |
arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131 19162293
|
| D013749 |
Tetrachlorodibenzodioxin |
EGTA acetoxymethyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 19162293
|
| D013749 |
Tetrachlorodibenzodioxin |
methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131
|
| D013749 |
Tetrachlorodibenzodioxin |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 18938131
|
| D013749 |
Tetrachlorodibenzodioxin |
[Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | affects cotreatment|decreases reaction|increases expression | 18938131
|
| D013749 |
Tetrachlorodibenzodioxin |
Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 19162293
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA | increases expression | 18938131 19162293
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of PLA2G4A protein | increases activity|increases phosphorylation | 19162293
|
| D013749 |
Tetrachlorodibenzodioxin |
arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 19063610
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PLA2G4A promoter] | affects binding|increases reaction | 19282623
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PLA2G4A mRNA | increases expression | 19933214 17942748
|
| D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased phosphorylation of PLA2G4A protein | increases phosphorylation | 10874129
|
| C113580 |
U 0126 |
U 0126 results in decreased phosphorylation of PLA2G4A protein | decreases phosphorylation | 17369491
|
| C113580 |
U 0126 |
U 0126 inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A mRNA] | decreases reaction|increases expression | 16603213
|
| C113580 |
U 0126 |
U 0126 inhibits the reaction [Ditiocarb results in increased expression of PLA2G4A protein] | decreases reaction|increases expression | 16603213
|
| D014635 |
Valproic Acid |
Valproic Acid results in increased expression of PLA2G4A mRNA | increases expression | 17594078
|
| D014635 |
Valproic Acid |
Valproic Acid results in increased expression of PLA2G4A protein | increases expression | 17594078
|
| D014810 |
Vitamin E |
Vitamin E inhibits the reaction [tert-Butylhydroperoxide results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 16291515
|
| D015032 |
Zinc |
Zinc results in increased expression of PLA2G4A mRNA | increases expression | 17074742
|
| D019287 |
Zinc Sulfate |
Zinc Sulfate results in increased expression of PLA2G4A mRNA | increases expression | 17074742
|
| D015054 |
Zymosan |
PLA2G4A protein promotes the reaction [Zymosan analog affects the localization of NCF1 protein] | affects localization|increases reaction | 12101222
|
| D015054 |
Zymosan |
PLA2G4A protein promotes the reaction [Zymosan analog affects the localization of NCF2 protein] | affects localization|increases reaction | 12101222
|
| D015054 |
Zymosan |
PLA2G4A protein promotes the reaction [Zymosan analog results in increased metabolism of Leukotriene B4] | increases metabolic processing|increases reaction | 11741884
|
| D015054 |
Zymosan |
Cycloheximide inhibits the reaction [Dexamethasone inhibits the reaction [Zymosan results in increased activity of PLA2G4A protein]] | decreases reaction|increases activity | 10874129
|
| D015054 |
Zymosan |
Dexamethasone inhibits the reaction [Zymosan results in increased activity of PLA2G4A protein] | decreases reaction|increases activity | 10874129
|
| D015054 |
Zymosan |
PLA2G4A protein affects the susceptibility to [Lipopolysaccharides co-treated with Zymosan] | affects cotreatment|affects response to substance | 10881173
|
| D015054 |
Zymosan |
PLA2G4A protein promotes the reaction [[Zymosan co-treated with Lipopolysaccharides] results in increased metabolism of Prostaglandins] | affects cotreatment|increases metabolic processing|increases reaction | 16787386
|
| D015054 |
Zymosan |
Zymosan results in increased phosphorylation of PLA2G4A protein | increases phosphorylation | 10874129
|
| D015054 |
Zymosan |
PLA2G5 protein promotes the reaction [Zymosan promotes the reaction [PLA2G4A protein results in increased metabolism of Eicosanoids]] | increases metabolic processing|increases reaction | 16407308
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
10.65 | 14745880 |
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
10.65 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-ethoxyethanol |
19.39 | 6499820 7151721 6499812 6499823 6499796 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
19.39 | 8986270 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
methyl cellosolve |
19.39 | 6474471 6499812 3652986 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
19.39 | 15322242 11752688 14514962 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
19.39 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.30 | 19490988 |
| MESH:D000138 |
Acidosis |
|
Zinc Sulfate |
4.21 | 7265320 |
| MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
4.80 | 17694057 |
| MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.70 | 16889938 17202136 17190629 |
| MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
6.97 | 12690470 17670903 15814532 |
| MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
6.97 | 7897758 |
| MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.39 | 11850527 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.97 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
10.97 | 11798837 17638652 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.97 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.97 | 17638652 |
| MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
10.97 | 11910360 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.48 | 6695378 |
| MESH:D000236 |
Adenoma |
|
Sulindac |
5.48 | 10223192 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
2.68 | 16835633 |
| MESH:D011125 |
Adenomatous Polyposis Coli |
|
celecoxib |
13.01 | 19003578 16215675 |
| MESH:D011125 |
Adenomatous Polyposis Coli |
|
Leukotriene B4 |
13.01 | 17942926 |
| MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
13.01 | 12394442 11874996 19003578 11535846 16460482 15623613 17611924 |
| MESH:D000544 |
Alzheimer Disease |
|
Aluminum |
10.21 | 10721010 17662457 |
| MESH:D000544 |
Alzheimer Disease |
|
Lithium |
10.21 | 19621015 |
| MESH:D000544 |
Alzheimer Disease |
|
Nitric Oxide |
10.21 | 17556102 |
| MESH:D000544 |
Alzheimer Disease |
|
Ozone |
10.21 | 15513908 |
| MESH:D000544 |
Alzheimer Disease |
|
Zinc |
10.21 | 16325427 16410023 17119284 16580781 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.52 | 17688650 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
marker/mechanism |
|
| 15816863 |
| MESH:D000740 |
Anemia |
|
Fluorouracil |
11.37 | 15504547 17963324 16511603 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
11.37 | 11748828 |
| MESH:D000740 |
Anemia |
|
Zymosan |
11.37 | 18664788 |
| MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.81 | 14761424 11369114 17661222 |
| MESH:D000748 |
Anemia, Macrocytic |
|
methyl cellosolve |
5.63 | 3699323 |
| MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.23 | 16916123 |
| MESH:D000860 |
Anoxia |
|
Zinc Sulfate |
4.32 | 7265320 |
| MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
7.43 | 18083778 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
7.43 | 17497229 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.39 | 19183758 |
| MESH:D001168 |
Arthritis |
|
Leukotriene B4 |
5.47 | 11006272 |
| MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
9.90 | 17659584 |
| MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
9.90 | 16690336 |
| MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
9.90 | 17659584 15142272 16872482 15188379 15944321 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.36 | 15570426 |
| MESH:D053627 |
Asthenozoospermia |
|
2-ethoxyethanol |
10.28 | 6499823 6499807 10689203 |
| MESH:D053627 |
Asthenozoospermia |
|
methyl cellosolve |
10.28 | 3987992 |
| MESH:D001249 |
Asthma |
|
fluticasone |
12.05 | 11596838 11991558 11101185 |
| MESH:D001249 |
Asthma |
|
Histamine |
12.05 | 16387687 |
| MESH:D001249 |
Asthma |
|
Leukotriene B4 |
12.05 | 11006272 19667530 |
| MESH:D001249 |
Asthma |
|
Ozone |
12.05 | 16373670 17854713 |
| MESH:D001249 |
Asthma |
|
Zinc |
12.05 | 17085522 |
| MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.11 | 20485159 12372130 |
| MESH:D001250 |
Asthma, Exercise-Induced |
|
Leukotriene B4 |
5.21 | 19667531 |
| MESH:D001259 |
Ataxia |
|
2-ethoxyethanol |
4.80 | 7151721 |
| MESH:D001284 |
Atrophy |
|
2-ethoxyethanol |
9.20 | 15850284 6499799 |
| MESH:D001284 |
Atrophy |
|
methyl cellosolve |
9.20 | 3699323 6705890 2626667 |
| MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15301788 |
| MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
2.34 | 18582451 |
| MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
2.34 | 18775368 19232924 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.34 | 16609825 18396377 17507914 17157402 18940202 19460635 20603192 19232924 18177632 17688650 18775368 18316065 18558336 18985861 15238991 |
| MESH:D053713 |
Azoospermia |
|
2-ethoxyethanol |
4.89 | 6492198 6499807 |
| MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
13.83 | 20046352 17594078 |
| MESH:D001714 |
Bipolar Disorder |
|
Lithium |
13.83 | 20338123 17594078 19153942 20046352 |
| MESH:D001714 |
Bipolar Disorder |
|
Lithium Carbonate |
13.83 | 19448189 17594078 19330793 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
13.83 | 17594078 20046352 |
| MESH:D001724 |
Birth Weight |
|
2-ethoxyethanol |
5.80 | 6499823 2884743 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.42 | 12125929 |
| MESH:D001791 |
Blood Platelet Disorders |
marker/mechanism |
|
| |
| MESH:D001836 |
Body Weight Changes |
|
2-ethoxyethanol |
9.66 | 6499796 7151721 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
9.66 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.40 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.40 | 8888407 |
| MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.52 | 16183116 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.17 | 14601052 |
| MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.64 | 11207687 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.62 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
8.78 | 15845082 15665606 15380490 |
| MESH:D001930 |
Brain Injuries |
|
Zinc |
8.78 | 17109824 |
| MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
3.81 | 15481559 |
| MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 21119660 |
| MESH:D001943 |
Breast Neoplasms |
|
Acrylamide |
9.43 | 16253758 18183576 |
| MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
9.43 | 15161893 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzene |
9.43 | 17162533 11921183 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
9.43 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
9.43 | 18382427 19526202 |
| MESH:D001943 |
Breast Neoplasms |
|
docetaxel |
9.43 | 18628466 16495393 19526202 15692762 17369602 16264153 15567936 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
9.43 | 16675129 17018787 12948864 19861407 17289903 18497071 14630087 17261762 |
| MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
9.43 | 16557594 18357371 15136595 16110121 18608205 16595493 19217205 |
| MESH:D001943 |
Breast Neoplasms |
|
Nitric Oxide |
9.43 | 15631943 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
9.43 | 15562024 16175315 17614352 |
| MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
9.43 | 16642371 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
9.43 | 19244106 19189212 18629630 19011961 16818667 16873071 18821012 19142967 16273361 21152245 17242785 19115204 19289846 18855134 19059307 15668708 19288272 15565566 19066611 19200415 20859285 16202921 19410462 18351453 20390343 17893378 20135344 20544844 17261762 17440819 20005174 19189210 18997820 19221464 17049068 11161223 18984771 19084267 18425577 18815881 21138602 19487384 20065188 19155303 19103187 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
9.43 | 20435547 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Leukotriene B4 |
7.24 | 12654629 12794006 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
7.24 | 15516495 17626835 18417511 19059883 18315731 16777450 14754758 |
| MESH:D001986 |
Bronchial Spasm |
|
Histamine |
5.11 | 18298128 |
| MESH:D029481 |
Bronchitis, Chronic |
|
fluticasone |
6.00 | 17687719 |
| MESH:D002100 |
Cachexia |
|
Ozone |
4.04 | 16183385 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.76 | 16111702 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
7.67 | 16011737 15721981 16124888 15700767 16097048 16192424 10355542 16050911 18705752 16227642 15673190 3786805 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
7.67 | 16050911 |
| MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
3.96 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Fluorouracil |
6.30 | 17121937 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.30 | 16835633 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.82 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
7.12 | 18788625 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
7.12 | 17982673 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
7.12 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
7.12 | 17088986 17045692 16799960 16332177 17971768 18930000 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
7.12 | 16924424 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
5.17 | 16685392 12023789 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
docetaxel |
5.17 | 11894018 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
celecoxib |
5.77 | 16369983 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
5.77 | 18695887 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
14.56 | 17015178 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.56 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
14.56 | 17066447 18337622 6189445 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
14.56 | 16757204 18986760 16280240 17066447 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
14.56 | 18922899 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
14.56 | 16543248 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.00 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
1.94 | 18850075 18670907 16120746 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.16 | 16936243 |
| MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
4.16 | 15003327 |
| MESH:D002418 |
Cattle Diseases |
|
Acrylamide |
4.74 | 12510666 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
8.33 | 18226522 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
8.33 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
8.33 | 18566989 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.41 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.56 | 16835633 |
| MESH:D002764 |
Cholecystitis |
|
2-ethoxyethanol |
11.28 | 6499794 |
| MESH:D002764 |
Cholecystitis |
|
methyl cellosolve |
11.28 | 6499794 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.56 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Nitric Oxide |
6.56 | 16919318 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.77 | 15340226 15668235 8697196 12621046 16354765 |
| MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
11.59 | 12411196 |
| MESH:D003110 |
Colonic Neoplasms |
|
celecoxib |
11.59 | 16004971 |
| MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
11.59 | 15824018 |
| MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
11.59 | 16340194 15001691 17169374 17725105 17172411 17016597 17287894 17018589 18772588 16510598 |
| MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
11.59 | 12902858 |
| MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
11.59 | 12902858 12458338 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
5.42 | 17047198 |
| MESH:D015179 |
Colorectal Neoplasms |
|
celecoxib |
5.42 | 11197048 18349538 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
5.42 | 15273666 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
5.42 | 16524972 18802399 18949393 18509181 18288408 16303861 16391804 18383874 17594712 20501625 15289873 17094418 18448328 17255274 16282729 15148649 17016601 17401013 14970324 16331619 17454858 17695437 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
5.42 | 10666051 18059344 11076880 11197048 |
| MESH:D000013 |
Congenital Abnormalities |
|
methyl cellosolve |
7.43 | 6499821 12530607 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.43 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
9.92 | 15643154 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
9.92 | 9014606 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
9.92 | 17728286 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
9.92 | 10048152 20055451 15322242 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
9.92 | 16575769 17688650 8888407 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
9.92 | 19769572 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
9.92 | 19302082 |
| MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.77 | 19747007 |
| MESH:D007644 |
Darier Disease |
|
Fluorouracil |
10.89 | 16733453 |
| MESH:D007644 |
Darier Disease |
|
Lithium |
10.89 | 20338123 |
| MESH:D003643 |
Death |
|
2-ethoxyethanol |
5.25 | 6499796 |
| MESH:D015140 |
Dementia, Vascular |
|
Nitric Oxide |
5.26 | 17556102 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.68 | 19031437 |
| MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
4.08 | 15014590 |
| MESH:D003872 |
Dermatitis |
marker/mechanism |
|
| 18287786 |
| MESH:D003872 |
Dermatitis |
|
Benzene |
4.08 | 15902427 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.77 | 12438553 |
| MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.06 | 19244398 |
| MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.61 | 16479319 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.46 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
6.85 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
6.85 | 19279558 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.81 | 17187935 |
| MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.51 | 12861449 17621415 |
| MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.06 | 7237001 |
| OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
4.76 | 11748493 |
| MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
3.94 | 16538175 20216337 16538176 15057820 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
9.14 | 11287661 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
9.14 | 17465707 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
9.14 | 19336974 15968718 7179309 16177239 15027814 4309450 6623471 16227642 3786805 19085960 15998439 9327722 10915739 7440962 6884620 11566570 21278145 17522070 10092053 2869522 3732212 7120509 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.14 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.14 | 1733752 19641884 |
| MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
10.75 | 20216337 |
| MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
10.75 | 12649298 15033597 19839026 12231392 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
10.75 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.40 | 1851702 |
| MESH:C538011 |
Eales disease |
|
Vitamin E |
3.99 | 9068938 |
| MESH:D004485 |
Eczema |
|
Dexamethasone |
3.79 | 12438553 |
| MESH:D004487 |
Edema |
|
Arachidonic Acid |
27.36 | 9599246 11698051 9831321 16716910 7990266 15177302 |
| MESH:D004487 |
Edema |
|
Aspirin |
27.36 | 17259670 |
| MESH:D004487 |
Edema |
|
Dexamethasone |
27.36 | 19703484 |
| MESH:D004487 |
Edema |
|
Fluoxetine |
27.36 | 12798668 |
| MESH:D004487 |
Edema |
|
L 663536 |
27.36 | 7990266 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
27.36 | 12711302 11000095 |
| MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
27.36 | 11698051 16716910 8113982 15177302 9599246 8273558 7812673 |
| MESH:D004487 |
Edema |
|
Zymosan |
27.36 | 7907874 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.19 | 15322242 18230668 16714409 |
| MESH:D020964 |
Embryo Loss |
|
2-ethoxyethanol |
5.80 | 6499796 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
11.70 | 17654737 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
11.70 | 17692515 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
11.70 | 19031437 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
5.75 | 19148513 11473722 18566989 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
5.75 | 16202921 20544844 17893378 19155303 |
| MESH:D004715 |
Endometriosis |
|
celecoxib |
22.16 | 15652904 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
22.16 | 16134523 |
| MESH:D004715 |
Endometriosis |
|
rofecoxib |
22.16 | 15652904 |
| MESH:D004715 |
Endometriosis |
|
Sulindac |
22.16 | 15652904 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
22.16 | 10568697 9294722 |
| MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.70 | 17637181 15821434 15328337 |
| MESH:D004802 |
Eosinophilia |
|
Histamine |
4.38 | 12689652 |
| MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
4.59 | 16538176 19915237 20485159 18855540 16415921 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
8.93 | 17275665 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
8.93 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
8.02 | 15008574 16628512 17116037 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
8.02 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Carbamazepine |
5.70 | 17178248 19700373 18234410 17465707 7988514 20417680 821787 19620853 19439326 9014606 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
5.70 | 20417680 18234410 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
2.99 | 7562514 6254150 6426943 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
9.44 | 7750514 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
9.44 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
8.57 | 15276670 3659116 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
8.57 | 3659116 |
| MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.02 | 19549232 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
17.48 | 16530937 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
17.48 | 15464296 16481741 15173087 16785472 17638652 |
| MESH:D004938 |
Esophageal Neoplasms |
|
docetaxel |
17.48 | 16337965 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
17.48 | 16337965 17638652 16481741 16785472 15173087 |
| MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
17.48 | 15623463 16805852 15547721 15547733 15150132 15878914 15264214 16510608 16704527 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
17.48 | 12235107 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
17.48 | 16543248 |
| MESH:D005076 |
Exanthema |
|
Carbamazepine |
4.77 | 20485159 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.47 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.64 | 12631006 12795759 15959796 17595544 16239168 61145 19224547 16045604 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.64 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
13.64 | 14986274 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.64 | 19224547 14986274 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.77 | 16709447 |
| MESH:D005313 |
Fetal Death |
|
2-ethoxyethanol |
8.57 | 2884743 7151721 6499823 7198755 6499820 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
8.57 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.17 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
2-ethoxyethanol |
8.99 | 6499796 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
8.99 | 18558336 8888407 |
| MESH:D005327 |
Fetal Resorption |
|
2-ethoxyethanol |
10.30 | 6499820 6499812 |
| MESH:D005327 |
Fetal Resorption |
|
methyl cellosolve |
10.30 | 6499812 6474471 3987992 6499821 |
| MESH:D020567 |
Fetal Weight |
|
2-ethoxyethanol |
11.28 | 6499820 2884743 7151721 |
| MESH:D020567 |
Fetal Weight |
|
methyl cellosolve |
11.28 | 6499821 6474471 6499812 |
| MESH:D005334 |
Fever |
|
Arachidonic Acid |
7.51 | 11852909 |
| MESH:D005334 |
Fever |
|
Lipopolysaccharides |
7.51 | 11852909 9205823 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
10.63 | 14745880 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
10.63 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
9.32 | 19069698 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
9.32 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
10.79 | 18705752 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.79 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
10.79 | 20067830 |
| MESH:D005532 |
Foot Deformities, Congenital |
|
methyl cellosolve |
4.81 | 3652986 |
| MESH:D005756 |
Gastritis |
|
Zinc |
4.09 | 17241300 |
| MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.34 | 11910360 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.52 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Aspirin |
3.47 | 12870263 |
| MESH:D005910 |
Glioma |
|
Fluorouracil |
2.54 | 16145905 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.88 | 10696789 |
| MESH:D006130 |
Growth Disorders |
|
Zinc |
3.48 | 17217573 |
| MESH:D006261 |
Headache |
|
Aspirin |
8.93 | 15240983 |
| MESH:D006261 |
Headache |
|
Nitric Oxide |
8.93 | 11554966 11284996 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
6.31 | 15102660 15464296 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
6.31 | 15162350 15102660 18337622 |
| MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.70 | 19898482 |
| MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.83 | 15464296 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
12.57 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
12.57 | 19638421 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
12.57 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
12.57 | 16080930 |
| MESH:D006333 |
Heart Failure |
|
Zinc |
3.15 | 17162251 |
| MESH:D006335 |
Heart Injuries |
|
Zinc |
5.05 | 17074742 |
| MESH:D006345 |
Heart Septal Defects, Ventricular |
|
methyl cellosolve |
5.08 | 6499821 |
| MESH:D016481 |
Helicobacter Infections |
|
Zinc |
3.88 | 17241300 |
| MESH:D006402 |
Hematologic Diseases |
|
2-ethoxyethanol |
9.17 | 20172899 10514026 |
| MESH:D006402 |
Hematologic Diseases |
|
Benzene |
9.17 | 16183116 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.72 | 15720958 |
| MESH:D006461 |
Hemolysis |
|
2-ethoxyethanol |
9.98 | 19051582 17874071 |
| MESH:D006461 |
Hemolysis |
|
methyl cellosolve |
9.98 | 17874071 |
| MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.77 | 16366002 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.70 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
7.46 | 19110552 19900420 |
| MESH:D006505 |
Hepatitis |
|
Zymosan |
7.46 | 19110552 |
| MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
9.05 | 17276780 |
| MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc Sulfate |
9.05 | 17063115 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.22 | 16120746 15340226 12621046 |
| MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
4.95 | 7520565 |
| MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
4.95 | 16863852 16490937 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.32 | 15709030 |
| MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.02 | 16200630 16170182 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
13.11 | 17088409 |
| MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
13.11 | 14716179 |
| MESH:D019584 |
Hot Flashes |
|
Vitamin E |
13.11 | 14716179 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.17 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.33 | 8697196 16959395 15340226 16354765 18606429 |
| MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.05 | 15240983 |
| MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.83 | 16899240 |
| MESH:D006940 |
Hyperemia |
|
Nitric Oxide |
4.91 | 11156591 |
| MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.13 | 10459572 |
| MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
4.53 | 18773962 |
| MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
3.90 | 17604070 |
| MESH:D006973 |
Hypertension |
|
Benzene |
12.92 | 17940673 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
12.92 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Dexamethasone |
12.92 | 17042910 |
| MESH:D006973 |
Hypertension |
|
Nifedipine |
12.92 | 20102058 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
12.92 | 18670907 18850075 |
| MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.40 | 15338365 |
| MESH:D006976 |
Hypertension, Pulmonary |
|
L 663536 |
7.32 | 14726295 |
| MESH:D006976 |
Hypertension, Pulmonary |
|
Nitric Oxide |
7.32 | 15838368 |
| MESH:D007022 |
Hypotension |
|
Zinc Sulfate |
3.83 | 7265320 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.72 | 15869954 |
| MESH:D007247 |
Infertility, Female |
|
2-ethoxyethanol |
8.88 | 6499823 |
| MESH:D007247 |
Infertility, Female |
|
Acrylamide |
8.88 | 11020651 |
| MESH:D007248 |
Infertility, Male |
|
2-ethoxyethanol |
8.86 | 6499823 |
| MESH:D007248 |
Infertility, Male |
|
Acrylamide |
8.86 | 15355880 12507653 11020651 15749267 |
| MESH:D007248 |
Infertility, Male |
|
methyl cellosolve |
8.86 | 3987992 |
| MESH:D007249 |
Inflammation |
|
Aluminum |
32.47 | 16052892 |
| MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
32.47 | 15177302 9831321 17371808 |
| MESH:D007249 |
Inflammation |
|
Dexamethasone |
32.47 | 11099482 8960868 |
| MESH:D007249 |
Inflammation |
|
Fluoxetine |
32.47 | 12798668 |
| MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
32.47 | 9205823 12878042 17963957 17237260 17255318 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
32.47 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Sulindac |
32.47 | 3291741 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
32.47 | 19457130 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
32.47 | 12200463 12878042 |
| MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
32.47 | 8273558 15177302 7812673 7562506 11698051 |
| MESH:D007249 |
Inflammation |
|
Zymosan |
32.47 | 11289658 8014878 |
| MESH:D015212 |
Inflammatory Bowel Diseases |
|
Leukotriene B4 |
4.14 | 11006272 |
| MESH:D007251 |
Influenza, Human |
|
Vitamin E |
3.50 | 16624496 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.48 | 16627594 16393666 |
| MESH:D007410 |
Intestinal Diseases |
|
Nitric Oxide |
8.31 | 10210152 11713966 11574821 |
| MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
8.31 | 15831440 |
| MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.02 | 12351151 12663524 10213222 12628509 12584176 10223192 |
| MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
9.47 | 11245490 |
| MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
9.47 | 12394442 11245490 |
| MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
3.98 | 17255318 |
| MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.14 | 17553498 |
| MESH:D007511 |
Ischemia |
|
Zinc |
3.95 | 16584753 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.70 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.73 | 15604871 |
| MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.43 | 15464296 |
| MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
14.32 | 18289764 12649298 15190930 12231392 19839026 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.32 | 18776723 10903974 8314463 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.32 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
14.32 | 12488133 |
| MESH:D007674 |
Kidney Diseases |
|
Zinc |
14.32 | 16960431 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
3.79 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.01 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.01 | 15610895 |
| MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
13.01 | 16985049 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
13.01 | 18625569 |
| MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.08 | 11231351 |
| MESH:D007896 |
Leishmaniasis |
|
Nitric Oxide |
4.06 | 17218153 |
| MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Zinc Sulfate |
3.69 | 15237267 |
| MESH:D007938 |
Leukemia |
|
Benzene |
3.00 | 17119257 14694614 15935818 18335105 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
4.61 | 16972261 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
3.69 | 17506065 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
3.52 | 19478238 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.52 | 17596541 16294345 |
| MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.00 | 15821434 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
methyl cellosolve |
3.97 | 6499821 |
| MESH:D008064 |
Lipidoses |
|
Fluoxetine |
6.58 | 17567588 15342952 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
6.58 | 15342952 17567588 |
| MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.39 | 17157831 16239168 17174718 21278145 11903743 11408273 16221502 17334410 16943688 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
3.75 | 12468960 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.87 | 17698563 17805973 18395095 13678700 18054572 17525996 12649538 15650968 16011737 18156304 14748882 15338365 16136751 18481824 18472094 17631135 14716833 18205269 17714472 15893842 17557913 15123356 16015684 15362042 15931870 11481614 17922224 18418968 17869086 14724832 18263696 18187930 17900296 12586293 12445418 15673190 16097048 18210741 18251166 17640975 18472332 18279442 18376398 15730626 12609069 18166357 18395914 16192424 14512876 18317297 15370692 17708605 15959796 12445421 12666154 16248980 17823541 17565644 16033810 15052691 14716496 16116963 12546737 17721639 18277467 15057751 15818738 12632514 16638106 20821823 17976157 15876570 17481882 18429990 15925388 10355542 14620537 17761835 18420326 17766677 18006644 17944888 12898905 12741479 12389079 18705752 18412020 12958196 18339082 12667390 15996030 12632512 16027843 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
10.87 | 16718785 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.87 | 14716833 14659978 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
10.87 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
10.87 | 17565644 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
10.87 | 18564211 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.87 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
10.87 | 16169303 |
| MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.63 | 17285989 15720792 16964402 16246199 15830285 |
| MESH:D008107 |
Liver Diseases |
|
Sulindac |
3.63 | 16867024 14986274 |
| MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.48 | 15123358 |
| MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.07 | 14706259 16899240 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.71 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
13.71 | 18177683 |
| MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
13.71 | 19294768 |
| MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
13.71 | 15113037 17045692 16603448 18383874 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
13.71 | 16684651 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.71 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
7.14 | 12562636 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
7.14 | 12014681 15583823 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
7.14 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
13.58 | 12815614 |
| MESH:D008171 |
Lung Diseases |
|
Aluminum |
13.58 | 16052892 |
| MESH:D008171 |
Lung Diseases |
|
Ozone |
13.58 | 19066396 8266340 |
| MESH:D008171 |
Lung Diseases |
|
Vitamin E |
13.58 | 16863852 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
9.02 | 14698565 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
9.02 | 17228818 |
| MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
11.42 | 21114838 |
| MESH:D055370 |
Lung Injury |
|
Nitric Oxide |
11.42 | 11395602 |
| MESH:D055370 |
Lung Injury |
|
Ozone |
11.42 | 20417186 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzene |
24.76 | 12562636 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
24.76 | 20464547 20869020 20064080 17053015 6695378 18520028 20135361 18569708 18816296 |
| MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
24.76 | 19359593 18597497 11246140 15390079 11696405 19925653 16337739 |
| MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
24.76 | 17225452 11798837 6189445 |
| MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
24.76 | 15824018 11195469 |
| MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
24.76 | 15246190 |
| MESH:D008175 |
Lung Neoplasms |
|
L 663536 |
24.76 | 15899809 |
| MESH:D008175 |
Lung Neoplasms |
|
Ozone |
24.76 | 8597069 7614698 |
| MESH:D008175 |
Lung Neoplasms |
|
Smoke |
24.76 | 11091918 |
| MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
24.76 | 19359593 15713900 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
24.76 | 18625569 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
24.76 | 19555203 11884234 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
24.76 | 11807781 |
| MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
24.76 | 11062179 |
| MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.09 | 15086387 |
| MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.32 | 16628512 |
| MESH:D008223 |
Lymphoma |
|
Benzene |
6.40 | 17584886 17119257 |
| MESH:D008223 |
Lymphoma |
|
Nitric Oxide |
6.40 | 16166326 |
| MESH:D008231 |
Lymphopenia |
|
methyl cellosolve |
5.08 | 3699323 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
7.76 | 12562636 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.76 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
25.04 | 11921183 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
25.04 | 1500032 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
celecoxib |
25.04 | 12104042 19196722 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
25.04 | 11807958 11408345 16891317 17203775 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
25.04 | 17203775 11408345 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
25.04 | 19196722 14580682 16827153 11731420 19196723 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
25.04 | 8985016 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
25.04 | 12773700 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.28 | 19453300 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.28 | 19453300 |
| MESH:D008545 |
Melanoma |
|
Cisplatin |
7.92 | 12393984 15577323 16248763 17023156 18332650 17761969 12883367 18505091 12374674 16432458 18176117 16809738 11135225 |
| MESH:D008545 |
Melanoma |
|
docetaxel |
7.92 | 12417787 |
| MESH:D008545 |
Melanoma |
|
Histamine |
7.92 | 17709802 |
| MESH:D008545 |
Melanoma |
|
Sulindac |
7.92 | 16642371 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.92 | 12393984 19393235 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
9.19 | 15990972 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
9.19 | 15990972 |
| MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
3.97 | 16856516 |
| MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.44 | 9014606 |
| MESH:D008654 |
Mesothelioma |
|
Cisplatin |
2.92 | 17638057 |
| MESH:D008661 |
Metabolism, Inborn Errors |
marker/mechanism |
|
| |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.07 | 16801185 |
| MESH:D008679 |
Metaplasia |
|
Ozone |
4.39 | 10496685 |
| MESH:D008881 |
Migraine Disorders |
|
Aspirin |
9.75 | 15240983 |
| MESH:D008881 |
Migraine Disorders |
|
Nitric Oxide |
9.75 | 11701602 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
9.75 | 18765137 18803445 |
| MESH:D020326 |
Migraine without Aura |
|
Nitric Oxide |
4.45 | 14659530 11304026 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
6.68 | 16381670 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
6.68 | 16757204 18986760 |
| MESH:D009101 |
Multiple Myeloma |
|
Benzene |
9.36 | 17119195 |
| MESH:D009101 |
Multiple Myeloma |
|
celecoxib |
9.36 | 16123214 |
| MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
9.36 | 15867202 16118317 15744524 |
| MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.56 | 18160304 12879239 15213630 10890648 12130978 15834315 10479408 17724436 15259001 15241586 |
| MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Aluminum |
5.66 | 17086897 |
| MESH:D020529 |
Multiple Sclerosis, Relapsing-Remitting |
|
Aluminum |
5.66 | 17086897 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.39 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
6.08 | 9809623 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.08 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
5.42 | 12692751 |
| MESH:D009203 |
Myocardial Infarction |
|
Lithium |
5.42 | 16288908 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.45 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.73 | 16810080 |
| MESH:D009207 |
Myoclonus |
|
Fluoxetine |
5.18 | 8041377 |
| MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
4.77 | 20399394 |
| MESH:D009325 |
Nausea |
|
Aspirin |
4.50 | 15240983 |
| MESH:D009336 |
Necrosis |
|
2-ethoxyethanol |
4.65 | 20172899 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
4.97 | 14720322 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
4.97 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.24 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
6.05 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Cisplatin |
6.05 | 16773208 |
| MESH:D009369 |
Neoplasms |
|
Fluorouracil |
6.05 | 16928823 18600527 18239605 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
celecoxib |
8.81 | 19196722 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
8.81 | 19189210 19200415 19196722 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.04 | 17289903 |
| MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.78 | 15464296 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.73 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.69 | 18481113 19348381 |
| MESH:D009410 |
Nerve Degeneration |
|
Acrylamide |
4.14 | 11264303 12387366 12387367 |
| MESH:D009422 |
Nervous System Diseases |
|
Acrylamide |
4.39 | 12164553 12507653 |
| MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
12.64 | 16990009 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
12.64 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
12.64 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
9.50 | 19446573 |
| MESH:D009436 |
Neural Tube Defects |
|
Benzene |
9.50 | 15643154 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
9.50 | 16359493 8888407 |
| MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.04 | 8761367 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
3.69 | 16850258 17266991 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.00 | 8761367 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
2.94 | 16436463 |
| MESH:D009503 |
Neutropenia |
|
Leukotriene B4 |
4.69 | 8305713 |
| MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
4.81 | 20418887 |
| MESH:D009784 |
Occupational Diseases |
|
Benzene |
3.57 | 15576619 15913788 17119257 15727169 17479406 17178637 15612468 15935809 16737584 |
| MESH:D009845 |
Oligospermia |
|
2-ethoxyethanol |
9.06 | 20172899 |
| MESH:D009845 |
Oligospermia |
|
methyl cellosolve |
9.06 | 3987992 |
| MESH:D010003 |
Osteoarthritis |
|
Aspirin |
6.73 | 7009135 |
| MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
6.73 | 16690336 |
| MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
4.77 | 17016548 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
11.96 | 12562636 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
11.96 | 15464296 19769630 17225452 6897625 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.96 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.96 | 16525653 17393432 |
| MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
11.96 | 16211241 |
| MESH:D010146 |
Pain |
|
Aspirin |
11.61 | 6363464 6995502 |
| MESH:D010146 |
Pain |
|
Carbamazepine |
11.61 | 15215642 |
| MESH:D010146 |
Pain |
|
Fluoxetine |
11.61 | 12798668 |
| MESH:D010146 |
Pain |
|
Sulindac |
11.61 | 3291741 |
| MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
4.68 | 16678543 18165598 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
13.02 | 19003803 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
13.02 | 16929163 15113037 19003803 16500647 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
L 663536 |
13.02 | 12384795 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
13.02 | 11504793 16820089 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
13.02 | 15976015 |
| MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.62 | 18404319 18922899 8330346 12065085 |
| MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.01 | 16538176 |
| MESH:D010300 |
Parkinson Disease |
|
Ditiocarb |
4.02 | 11445065 |
| OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.22 | 17679678 17145499 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.53 | 12520081 |
| MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
4.84 | 11156591 |
| MESH:D010523 |
Peripheral Nervous System Diseases |
|
Acrylamide |
8.20 | 11510240 |
| MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
8.20 | 15464296 |
| MESH:D010538 |
Peritonitis |
|
Ozone |
8.15 | 16369182 |
| MESH:D010538 |
Peritonitis |
|
Zymosan |
8.15 | 14761945 18557954 18760300 17371808 18977430 19088179 17826846 19641140 15979727 15259001 11985352 |
| MESH:D020795 |
Photophobia |
|
Aspirin |
5.05 | 15240983 |
| MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
5.31 | 8041377 |
| MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.63 | 17638057 |
| MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
14.64 | 11893704 |
| MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
14.64 | 11605937 12224865 |
| MESH:D011014 |
Pneumonia |
|
Ozone |
14.64 | 18929643 18007984 18381685 |
| MESH:D011015 |
Pneumonia, Aspiration |
|
Nitric Oxide |
4.64 | 18573544 |
| MESH:D011041 |
Poisoning |
|
Diphenhydramine |
5.27 | 12460839 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.89 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.63 | 12371664 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.11 | 21297632 |
| MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.62 | 17114810 |
| MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
4.47 | 9014606 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
2-ethoxyethanol |
23.16 | 2884743 7198755 6499817 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
23.16 | 9014606 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
methyl cellosolve |
23.16 | 6499817 12530607 7974496 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
23.16 | 11118676 11399792 11896295 11222880 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
23.16 | 20603192 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.25 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.57 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
celecoxib |
2.57 | 15570007 17908994 |
| MESH:D011471 |
Prostatic Neoplasms |
|
docetaxel |
2.57 | 16644109 18824434 16520278 19103299 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.57 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.57 | 18626508 19082440 |
| MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.57 | 16205645 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.57 | 15067354 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.57 | 15084515 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.57 | 16606632 12429649 16700911 16517595 |
| MESH:D011537 |
Pruritus |
|
L 663536 |
4.96 | 17827870 |
| MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
10.23 | 9591791 12752131 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
10.23 | 12752131 11422049 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.22 | 16882103 |
| MESH:D011565 |
Psoriasis |
|
Leukotriene B4 |
5.22 | 11006272 |
| MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.41 | 15538739 16160472 18722050 18286688 |
| MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
3.73 | 15464296 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
marker/mechanism |
|
| 10881173 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
7.35 | 12210543 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.35 | 18379247 11700416 |
| MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.24 | 10835634 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.17 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.58 | 16584753 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.52 | 19155313 |
| MESH:D012220 |
Rhinitis |
|
Aspirin |
7.41 | 12372130 |
| MESH:D012220 |
Rhinitis |
|
Histamine |
7.41 | 12689652 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.56 | 18045962 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
3.76 | 14601052 |
| MESH:D012555 |
Schistosomiasis mansoni |
|
Nitric Oxide |
4.78 | 9673227 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
1.96 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
Carbamazepine |
7.27 | 9844417 9046859 16876388 15946322 19414003 16938433 16180713 |
| MESH:D012640 |
Seizures |
|
Lithium |
7.27 | 19660546 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
7.27 | 17978042 1511512 11738929 14763951 3137016 11044598 15475178 16876388 |
| MESH:D018805 |
Sepsis |
|
Zymosan |
4.06 | 11441115 |
| MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
5.18 | 8704074 |
| MESH:D012772 |
Shock, Septic |
|
Diphenhydramine |
5.77 | 18063050 |
| MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
4.58 | 12269725 |
| MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.22 | 18709164 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
10.39 | 10029692 19755658 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
10.39 | 8532709 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
10.39 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
10.39 | 8330346 12065085 18404319 8985016 11807781 |
| MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
4.43 | 19414003 |
| MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.63 | 15464296 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.58 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
8.55 | 16503802 15862959 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
8.55 | 19457130 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.22 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Lithium |
10.30 | 19951488 19430551 19570321 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
10.30 | 12833885 |
| MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
4.53 | 19694795 15057820 19915237 16415921 16538176 18855540 20485159 |
| MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.63 | 15472012 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
8.67 | 12562636 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
8.67 | 20155912 2093021 |
| MESH:D013274 |
Stomach Neoplasms |
|
celecoxib |
8.67 | 15609394 |
| MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
8.67 | 15958060 17522103 18396642 |
| MESH:D013274 |
Stomach Neoplasms |
|
docetaxel |
8.67 | 16557585 |
| MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
8.67 | 18567086 17522103 16951190 16424979 19015929 17498489 19084572 18396642 17172411 15786421 |
| MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
8.67 | 17575124 12958204 |
| MESH:D013276 |
Stomach Ulcer |
|
2-ethoxyethanol |
16.03 | 6499799 |
| MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
16.03 | 17918041 |
| MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
16.03 | 15138204 |
| MESH:D013276 |
Stomach Ulcer |
|
Nifedipine |
16.03 | 14653237 |
| MESH:D013276 |
Stomach Ulcer |
|
Nitric Oxide |
16.03 | 15138204 |
| MESH:D020521 |
Stroke |
|
Aspirin |
7.02 | 16403987 |
| MESH:D020521 |
Stroke |
|
Vitamin E |
7.02 | 16517955 |
| MESH:D013733 |
Testicular Diseases |
|
2-ethoxyethanol |
13.65 | 10514026 6499806 10048760 |
| MESH:D013733 |
Testicular Diseases |
|
Acrylamide |
13.65 | 15864552 |
| MESH:D013733 |
Testicular Diseases |
|
methyl cellosolve |
13.65 | 6499806 |
| MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
3.98 | 15464296 17225452 |
| MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.55 | 15821434 |
| MESH:D013927 |
Thrombosis |
|
Aspirin |
3.92 | 17672075 |
| MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.26 | 10850423 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.19 | 12697716 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.97 | 19048282 |
| MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.01 | 16280240 |
| MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
8.01 | 16543248 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.52 | 17262798 |
| MESH:D014456 |
Ulcer |
marker/mechanism |
|
| |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
3.82 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
9.27 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
9.27 | 17225452 12973940 15464296 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
9.27 | 17572228 16712894 8653321 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
terephthalic acid |
9.27 | 16621493 16896691 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
3.96 | 8888407 |
| MESH:D014581 |
Urticaria |
|
Aspirin |
7.52 | 10982225 20485159 |
| MESH:D014581 |
Urticaria |
|
Histamine |
7.52 | 18298128 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
7.60 | 16803524 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
7.60 | 16803524 |
| MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
12.58 | 12562636 |
| MESH:D014594 |
Uterine Neoplasms |
|
celecoxib |
12.58 | 18645019 |
| MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
12.58 | 18645019 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
16.19 | 1336536 |
| MESH:D014605 |
Uveitis |
|
Dexamethasone |
16.19 | 1336536 |
| MESH:D014605 |
Uveitis |
|
Zymosan |
16.19 | 11006244 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
3.93 | 15577323 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.88 | 12125929 |
| MESH:D014839 |
Vomiting |
|
Cisplatin |
4.01 | 11897121 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.53 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.73 | 17120751 |